Vanicream Hc Anti-itch Cream
NDC Package 45334-327-04
Package Information
Vanicream Hc Anti-itch (hydrocortisone) cream is a medication used to treat a variety of skin conditions (e.g., insect bites, poison oak/ivy, eczema, dermatitis, allergies, rash, itching of the outer female genitals, anal itching). This formulation utilizes a cream delivery system. Marketed by Pharmaceutical Specialties, Inc., this product is identified by NDC 45334-327 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 106258 - hydrocortisone 1 % Topical Cream
- RxCUI: 106258 - hydrocortisone 10 MG/ML Topical Cream
- RxCUI: 106258 - hydrocortisone 1 % (as hydrocortisone acetate 1.2 % ) Topical Cream
- RxCUI: 106258 - hydrocortisone 1 GM per 100 GM Topical Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 45334 - Pharmaceutical Specialties, Inc.
- 45334-327 - Vanicream Hc Anti-itch
- 45334-327-04 - 4 g in 1 TUBE
- 45334-327 - Vanicream Hc Anti-itch
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (45334-327). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 45334-327-04 identifies a specific commercial package of 4 g in 1 tube of Vanicream Hc Anti-itch, a human over the counter drug labeled by Pharmaceutical Specialties, Inc.. This cream is formulated for topical use and contains hydrocortisone acetate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pharmaceutical Specialties, Inc. on January 26, 2016.
What are the primary indications for this medication?
This medication is used to treat a variety of skin conditions (e.g., insect bites, poison oak/ivy, eczema, dermatitis, allergies, rash, itching of the outer female genitals, anal itching). Hydrocortisone reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a mild corticosteroid.
How is this Pharmaceutical Specialties, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 45334032704. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.